Nicotine & Tobacco: Current issues, Policy and Practice / 21st – 24th May 2018 / University of Stirling

Building on our previous CPD courses on tobacco control and alcohol policy, the UK Centre for Tobacco and Alcohol Studies is delighted to be offering our Nicotine & Tobacco CPD course at the University of Stirling in 2018!

Please note: If you book on/before 28th February 2018, the cost is: £499, or £649 for students seeking accreditation. 

The course, successfully introduced in 2015, is aimed at professionals working in a range of organisations who are interested in public health and policy in the UK or internationally. In addition to the topics covered at previous tobacco CPDs, this year we will be examining the current, up to date evidence on tobacco harm reduction, electronic cigarettes and other nicotine-containing devices.

On successful completion of the module, students will be able to:

• Describe and discuss patterns of tobacco consumption, prevalence and addiction and the rise of e-cigarette use.
• Assess key milestones in tobacco and nicotine policy and the contribution of policy in developing and implementing effective interventions.
• Critically discuss the role of commercial interests, including the tobacco industry, in promoting tobacco use and recent controversies regarding the e-cigarette industry.
• Describe and discuss the range of effective interventions to reduce tobacco use and the place of tobacco harm reduction, including e-cigarettes, in addressing tobacco use.
• Assess the potential impact of current and emerging tobacco control priorities on different population groups, including tobacco harm reduction approaches.
• Discuss principles of media advocacy as applied to current issues in tobacco control.


*NEW FOR 2018*

ADDITIONAL BREAKOUT SESSIONS RELEVANT TO INTERNATIONAL TOBACCO CONTROL!

TAXATION & ILLICIT TOBACCO
Deborah Arnott, Action on Smoking & Health (ASH)
SMOKELESS TOBACCO
Prof. Kamran Siddiqi, University of York
TOBACCO MARKETING
Crawford Moodie, University of Stirling
Advertisements

Presentations from the 2017 e-cigarette summit | November 2017

The 5th annual E-Cigarette Summit was held at the Royal Society in London on Friday 17th November 2017. Linda Bauld, Robert West and several other members of the UKCTAS network presented their research at the event to a large audience of other scientists, policy makers, medical and public health professionals and e-cigarette stakeholders. The presentations included the latest evidence on the safety of e-cigarettes for users and bystanders, usage in young people and non-smokers, advertising and marketing, use in public places and the conflicts arising from the tobacco industry’s dual corporate ownership of tobacco harm reduction products and cigarettes.

To view the slides from each presentation and the full list of videos click here.

Robert West (University College London) & Linda Bauld (University of Stirling):

Panel Discussion:

Lion Shahab (University College London) & Jamie Hartmann-Boyce (University of Oxford):

Deborah Arnott (ASH) & Martin Dockrell (Public Health England):

See more information about the event and view each of the lecture slides.

 

Upcoming Tobacco & Alcohol courses now taking applications: limited places available!

nottingham

“Tobacco Control Interventions”
29th Jan – 2nd Feb 2018
University of Nottingham

Closing date for applications: 16th January 2018

This year we will be discussing important factors in tobacco control including; youth smoking, the role of the tobacco industry, use of mass media for smoking prevention and cessation, smokefree legislation, harm reduction and the neurobiology of nicotine addiction.


kcl_front_ukctas

“Alcohol, Problems, Policy & Practice” 
5th – 9th February 2018
Kings College London

Early bird deadline: 21st December 2017

The course is a mixture of blended learning, with face-to-face lectures being held in February 2018. It is open to all UKCTAS researchers as well as students of the MSc in Addiction Studies.


stirling-banner

“Nicotine and Tobacco CPD”
21st – 24th May 2018
University of Stirling

Early bird deadline: 28th February 2018

In addition to the topics covered on our previous tobacco control CPD, we will also be examining in detail the current evidence on tobacco harm reduction, electronic cigarettes and other nicotine-containing devices.


More information about these courses can be found on our website @ UKCTAS.net

Are you a vaper who also smokes? Would you be willing to help with an important study at QMUL?

How does dual use of e-cigarettes and conventional cigarettes change over time?

The Study:

This study is being run by the Health and Lifestyle Research Unit at Queen Mary University of London, and is funded by Cancer Research UK (CRUK).

Many people who smoke conventional cigarettes also use an e-cigarette and this is called ‘dual use’. Little is known about the way such use develops over time. Most dual users aim to stop smoking altogether, but many people continue using both products. It is not clear at present how many of these dual users stop smoking, at which time point, and what factors help them to stop.

We are inviting up to 500 dual users to take part in a study which aims to gain a greater understanding of these issues. If you take part, we will ask you questions about your vaping and smoking over the telephone or internet at 3 monthly intervals, over a 12-month period. The surveys should take approximately 10 minutes each to complete. You will receive a £15 voucher as compensation for your time. The study is funded for 1 year initially, but if we obtain further funding, we will extend the follow-up period to 10 years.

We hope that the results of this trial will inform what advice doctors and other health professionals give on e-cigarettes in the future.

Who can take part?

You will be able to take part if you are:

  • Aged 18 years or over.
  • Currently using both an e-cigarette and conventional cigarettes either on the same or separate days for at least one day a week, and practiced such use for at least one month.
  • Willing to provide data on your vaping and smoking at baseline, 3, 6, 9 and 12 months.
  • Are not currently taking part in another conflicting study.

Thank you for your interest in this study. It is important that you understand what is involved before you consent to take part. There is information at the end of the information leaflet on how to contact the study organiser if you have any questions or concerns. Your participation is completely voluntary and will not affect any access to treatment or services that you may be currently receiving.

If you are interested in taking part please call: 0207 882 5747 (lines are open Monday-Friday, 9-5pm) Or click the link to email us: health-research@qmul.ac.uk

For more information and to apply to take part in this study click here!

 

 

 

E-Cigarette Summit 2017 – Friday 17th November | Royal Society, London

cropped-summit-logo-2017

Since the inaugural meeting in November 2013, The E-Cigarette Summit has been at the forefront of taking forward the scientific and public health debate around e-cigarettes and broader harm reduction debates. The Summit has established itself as a neutral environment for scientists, policy makers, medical and public health professionals and stakeholders to come together and look at the latest scientific research and evidence on e-cigarettes and debate their impact. In 2013, the conversation was UK centric as the public health and policy communities sought to find an appropriate regulatory system for e-cigarettes that would reflect the opportunities for smokers without ignoring potential harms. In the intervening years, the UK has emerged as an active proponent for tobacco harm reduction alongside stringent tobacco control measures and now five years on the Summit welcomes scientists, public health professionals and policy makers from around the world who are looking to establish their own regulatory framework in the face of new nicotine products.

Alongside the latest evidence on the safety of e-cigarettes for users and bystanders, The E-Cigarette Summit will continue to address broader debates including evidence on “gateway” for youth and non-smokers, advertising and marketing, use in public places and the conflicts arising from the tobacco industry’s dual corporate ownership of tobacco harm reduction products and cigarettes. The role that e-cigarettes could play in ending or extending the smoking epidemic will remain one of the most fiercely fought debates in public health history.

For governments and policy makers/advisors, the weight of making the right decision cannot be underestimated. From outright bans, advertising restrictions to higher taxation; the way that each country introduces, interprets and implements legislation, including consumer and medical licensing routes, will have far reaching consequences. Setting the regulatory bar at the correct level, will be vital to harnessing the opportunities that e-cigarettes and reduced harm nicotine products could offer while remaining responsive to a tobacco control manifesto to reduce smoking related harm.

What questions will be explored?

The E-Cigarette Summit will include high level briefings from experts and encourages interaction through panel debates and open floor discussions. Questions will be explored in a balanced and objective environment allowing attendees to build their knowledge and share their viewpoints.

This year the summit will explore the latest research and evidence on the following areas:

  • The Continuum of Harm Reduction and different policy/regulatory approaches.
  • E-Cigarette safety and research
  • Nicotine health impacts including addiction
  • Dual use – how concerned should we be?
  • Heat not Burn and E-cigarettes – similarities and differences
  • Advertising restrictions – how to reach smokers and protect youth?
  • Medicinal Licensing – is this a viable route and where are the products?
  • What does the evidence say about gateway?
  • Are there health risks through second hand vapour for non-users?
  • If e-cigarettes are so good, why aren’t all smokers using them?

Who Should Attend?

In particular, this event will be relevant to:

  • Regulators and policy advisors
  • Scientific/research community
  • Smoking cessation practitioners/services
  • Health providers, health charities and health campaigners
  • Local Authorities and Environmental Health
  • Public health professionals and academics
  • Medical and health professionals
  • e-cigarette industry and broader stakeholders groups

This years summit welcomes many researchers from around the world, including many who are part of the UKCTAS network. Including; Professor Linda Bauld from the University of Stirling, Professor Ann McNeill from King’s College London, Dr Jamie Hartmann-Boyce from the University of Oxford and Professor Robert West from University College London. The summit will also feature inputs from the Department of Health, Public Health England and many more public health organisations. To see the full list of speakers click here.

Early Bird Rates are valid until Friday 20th October!

To register for this event or to find out more information, click here!

UKCTAS comment on the latest tobacco control plan for England: “Towards a smoke-free generation”

The new tobacco control plan, ‘Towards a smoke free generation’ is a welcome restatement of the government’s commitment to reduce the prevalence, and hence the burden of death and disability caused, by smoking. The recognition that harm reduction strategies can play a key role in achieving these ambitions is applauded, and puts the UK at the forefront of global tobacco policy. However, the ambition to reduce adult smoking in England from 15.5% to 12% by 2022, representing as it does a reduction of 0.5 of a percentage point per year, is modest given that smoking prevalence has fallen by 2.9 percentage points in the last three years.

Recognising reducing smoking in pregnancy as a priority, and aiming to reduce prevalence in pregnancy to 6% or less, is welcome but will not be achieved without adequate resources, improved care pathways and addressing significant gaps in training for midwives and obstetricians. The commitment to make NHS inpatient mental health settings smoke-free by 2018 is long overdue, but it is disappointing that the same strong commitment is not extended to other NHS settings.

The ambition to make stop-smoking services more available is also welcome, but like the commitments to NHS settings and for pregnancy requires funding: when public health budgets are being slashed, how will local authorities afford to increase their smoking service provision?

What matters now is delivery: Action to achieve and exceed these ambitions is the next and crucial step

PDF of the Press Release

Prof Linda Bauld on E-cigarette use during pregnancy at GFN 2017

Global Forum on Nicotine 2017 – ‘Reducing Harm, Saving Lives’

E-cigarette use during pregnancy – What do we know?

At the June Global Forum on Nicotine event Professor Linda Bauld from the University of Stirling and Deputy Director of the UK Centre for Tobacco and Alcohol Studies, presented an update on e-cigarette use during pregnancy. In the presentation Linda highlights the latest research, a brief overview of smoking in pregnancy and why pregnant women who are still smoking should be encouraged to switch to e-cigarettes.

External link for video: E-cigarette use during pregnancy – Professor Linda Bauld

Other links:

Smokefree action’s info-graphic on e-cigarettes in pregnancy

To see other presentations from the conference click here.

Latest press release from UKCTAS:

Vaping may help explain the record fall in UK smoking rates